Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 287 participants.
Also called NCT03349684
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 287 participants
- Sponsor
- Registry
-
NCT03349684
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03349684. Randomized; quadruple masking; primary purpose treatment. Start 2018-03-05 (actual); primary completion 2019-08-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Acarbose
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct03349684- Content hash
d1f5b6997eebb9f6767ca694775bc9ba97b522d05df2aea30236413bade445dd